WHO Updates the Nomenclature of SARS-CoV-2 Variants
WHO Updates the Nomenclature of SARS-CoV-2 Variants
Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.
WHO Updates the Nomenclature of SARS-CoV-2 Variants
WHO Updates the Nomenclature of SARS-CoV-2 Variants

Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.

Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.

b.1.1.7
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Lisa Winter | May 6, 2021
Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Asher Jones | Feb 16, 2021
B.1.525 shares a mutation with the B.1.351 variant first detected in South Africa that seems to allow the virus to dodge the immune system.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena | Feb 16, 2021
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021
Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.
Special report
A Guide to Emerging SARS-CoV-2 Variants
A Guide to Emerging SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021
Scientists across the world are closely tracking the spread of mutations in the coronavirus and investigating whether they could render current vaccines less effective.
Moderna Developing Booster Shot for New Virus Variant B.1.351
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
Data Hint B.1.1.7 Could Be More Deadly Than Thought
Data Hint B.1.1.7 Could Be More Deadly Than Thought
Shawna Williams | Jan 25, 2021
In addition to being more transmissible, the variant now dominant in the UK may be about 30 percent more deadly than previous strains, but much uncertainty remains.
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Kerry Grens | Jan 8, 2021
An engineered coronavirus with the N501Y mutation—one of many mutations present in the emerging B.1.1.7 and 501.V2 variants of the coronavirus—is neutralized by the sera of COVID-19 vaccine recipients.